900000000000523009: POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

900000000001150016 POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001151017 POSSIBLY EQUIVALENT TO association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)	Is a	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Methemoglobin reductase deficiency	A rare red cell disorder classified principally into two clinical phenotypes: autosomal recessive congenital (or hereditary) types I and II (RCM/RHM type 1; RCM/RHM type 2). In RCM type 1, cyanosis from birth is the only symptom. RCM type 2 is much more severe; the cyanosis is accompanied by neurological dysfunction (with intellectual deficit, microcephaly, growth retardation, opisthotonus, strabismus and hypertonia), which usually becomes evident during the first four months of life. RCM type 1 is caused by mutations of the CYB5R3 gene (22q13.31-qter) encoding the NADH-cytochrome b5 reductase (Cb5R) and Cb5R deficiency is limited to the erythrocytes. RCM type 2 is caused by global loss of Cb5R function. RCM type 1 is generally associated with missense mutations, whereas RCM type 2 is more commonly associated with truncating mutations, splicing errors or mutations that lead to disruption of the active site.
Method for measuring height	Body height measure
Method of catheter fixation	Securing of catheter (procedure)
Method of drug administration	Method of drug administration (observable entity)
Methotrexate 100mg/mL injection solution 10mL vial	Methotrexate (as methotrexate sodium) 100 mg/mL solution for injection
Methotrexate 100mg/mL injection solution 50mL vial	Methotrexate (as methotrexate sodium) 100 mg/mL solution for injection
Methotrexate 2.5mg/mL injection solution 2mL vial	Methotrexate (as methotrexate sodium) 2.5 mg/mL solution for injection
Methotrexate 25mg/mL injection solution 200mL vial	Product containing precisely methotrexate (as methotrexate sodium) 25 milligram/1 milliliter conventional release solution for injection (clinical drug)
Methotrexate 25mg/mL injection solution 20mL vial	Product containing precisely methotrexate (as methotrexate sodium) 25 milligram/1 milliliter conventional release solution for injection (clinical drug)
Methotrexate 25mg/mL injection solution 2mL vial	Product containing precisely methotrexate (as methotrexate sodium) 25 milligram/1 milliliter conventional release solution for injection (clinical drug)
Methotrexate 25mg/mL injection solution 40mL vial	Product containing precisely methotrexate (as methotrexate sodium) 25 milligram/1 milliliter conventional release solution for injection (clinical drug)
Methotrexate 25mg/mL injection solution 8mL vial	Product containing precisely methotrexate (as methotrexate sodium) 25 milligram/1 milliliter conventional release solution for injection (clinical drug)
Methotrexate and derivative	Pteridine
Methotrexate lpf 25mg/mL preservative free injection	Product containing precisely methotrexate (as methotrexate sodium) 25 milligram/1 milliliter conventional release solution for injection (clinical drug)
Methotrimeprazine hydrochloride 25mg/1mL injection	Levomepromazine hydrochloride 25 mg/mL solution for injection
Methoxamine hydrochloride 20mg/1mL injection	Methoxamine hydrochloride 20 mg/mL solution for injection
Methoxy polyethylene glycol-epoetin beta 150micrograms injection solution 0.3mL prefilled syringe	Methoxy polyethylene glycol-epoetin beta 500 microgram/mL solution for injection
Methoxy polyethylene glycol-epoetin beta 200micrograms injection solution 0.3mL prefilled syringe	Methoxy polyethylene glycol-epoetin beta 666.667 microgram/mL solution for injection
Methoxy polyethylene glycol-epoetin beta 250micrograms injection solution 0.3mL prefilled syringe	Product containing precisely methoxy polyethylene glycol-epoetin beta 833.333 microgram/1 milliliter conventional release solution for injection (clinical drug)
Methoxy polyethylene glycol-epoetin beta 50micrograms injection solution 0.3mL prefilled syringe	Methoxy polyethylene glycol-epoetin beta 166.667 microgram/mL solution for injection
Methoxy polyethylene glycol-epoetin beta 75micrograms injection solution 0.3mL prefilled syringe	Methoxy polyethylene glycol-epoetin beta 250 microgram/mL solution for injection
Methscopolamine m/r	Product containing methscopolamine (medicinal product)
Methyfentanyl	3-methylfentanyl (substance)
Methyl alcohol	Methyl alcohol
Methyl malonic acid	Methyl malonic acid
Methyl malonic acid	Methylmalonate (substance)
Methyl malonic acid excretion test	Methyl malonic acid excretion measurement (procedure)
Methyl salicylate powder	Product containing methyl salicylate in cutaneous dose form (medicinal product form)
Methyl violet stain	Methyl violet 6B stain (substance)
Methyl violet stain	Methylrosanilinium chloride
Methyl violet stain	Methyl violet 2B stain (substance)
Methyl violet stain method	Gentian violet stain method (procedure)
Methyl violet stain method	Methyl violet 6B stain method (procedure)
Methyl violet stain method	Methyl violet 2B stain method (procedure)
Methylcellulose granules	Product containing methylcellulose (medicinal product)
Methyldopa and diuretic adverse reaction	Diuretic adverse reaction
Methyldopa and diuretic adverse reaction	Methyldopa adverse reaction
Methylnaltrexone 12mg injection solution 0.6mL vial	Product containing precisely methylnaltrexone bromide 20 milligram/1 milliliter conventional release solution for injection (clinical drug)
Methylobacterium species	Methylobacterium
Methylophilus species	Methylophilus
Methylphenidate hydrochloride 10mg m/r capsule	Product containing precisely methylphenidate hydrochloride 10 milligram/1 each prolonged-release oral capsule (clinical drug)
Methylphenidate hydrochloride 18mg m/r tablet	Product containing precisely methylphenidate hydrochloride 18 milligram/1 each prolonged-release oral tablet (clinical drug)
Methylphenidate hydrochloride 18mg m/r tablet	Product containing precisely methylphenidate hydrochloride 18 milligram/1 each prolonged-release oral tablet (clinical drug)
Methylphenidate hydrochloride 20mg m/r capsule	Methylphenidate hydrochloride 20 mg prolonged-release oral capsule
Methylphenidate hydrochloride 20mg m/r capsule	Methylphenidate hydrochloride 20 mg prolonged-release oral capsule
Methylphenidate hydrochloride 20mg m/r tablet	Product containing precisely methylphenidate hydrochloride 20 milligram/1 each prolonged-release oral tablet (clinical drug)
Methylphenidate hydrochloride 27mg m/r tablet	Product containing precisely methylphenidate hydrochloride 27 milligram/1 each prolonged-release oral tablet (clinical drug)
Methylphenidate hydrochloride 30mg m/r capsule	Product containing precisely methylphenidate hydrochloride 30 milligram/1 each prolonged-release oral capsule (clinical drug)
Methylphenidate hydrochloride 36mg m/r tablet	Methylphenidate hydrochloride 36 mg prolonged-release oral tablet
Methylphenidate hydrochloride 36mg m/r tablet	Methylphenidate hydrochloride 36 mg prolonged-release oral tablet
Methylphenidate hydrochloride 40mg m/r capsule	Methylphenidate hydrochloride 40 mg prolonged-release oral capsule
Methylphenidate hydrochloride 50mg m/r capsule	Methylphenidate hydrochloride 50 mg prolonged-release oral capsule
Methylphenidate hydrochloride 54mg m/r tablet	Methylphenidate hydrochloride 54 mg prolonged-release oral tablet
Methylprednisolone acetate 120mg/3mL injection	Methylprednisolone acetate 40 mg/mL suspension for injection
Methylprednisolone acetate 40mg suspension	Methylprednisolone acetate 40 mg/mL suspension for injection
Methylprednisolone acetate 40mg/1mL injection	Methylprednisolone acetate 40 mg/mL suspension for injection
Methylprednisolone acetate 40mg/mL	Methylprednisolone acetate 40 mg/mL suspension for injection
Methylprednisolone acetate 40mg/mL injection suspension 1mL vial	Methylprednisolone acetate 40 mg/mL suspension for injection
Methylprednisolone acetate 40mg/mL injection suspension 2mL vial	Methylprednisolone acetate 40 mg/mL suspension for injection
Methylprednisolone acetate 40mg/mL injection suspension 3mL vial	Methylprednisolone acetate 40 mg/mL suspension for injection
Methylprednisolone acetate 40mg/mL suspension	Methylprednisolone acetate 40 mg/mL suspension for injection
Methylprednisolone acetate+lidocaine hydrochloride 40/10mg/1mL injection	Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug)
Methylprednisolone acetate+lidocaine hydrochloride 80/20mg/2mL injection	Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug)
Metoclopramide hydrochloride 15mg m/r capsule	Product containing precisely metoclopramide hydrochloride 15 milligram/1 each prolonged-release oral capsule (clinical drug)
Metoclopramide hydrochloride 15mg m/r tablet	Metoclopramide hydrochloride 15 mg prolonged-release oral tablet
Metoclopramide hydrochloride 5mg/5mL s/f oral solution	Product containing precisely metoclopramide hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug)
Metoprolol tartrate+hydrochlorothiazide 200mg/25mg m/r tablet	Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 200 milligram/1 each prolonged-release oral tablet (clinical drug)
Metrizoate	Product containing metrizoate (medicinal product)
Metronidazole 0.75%	Metronidazole 7.5 mg/g vaginal gel
Metronidazole 0.75%	Product containing precisely metronidazole 7.5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)
Metronidazole and tinidazole	Product containing tinidazole (medicinal product)
Metronidazole and tinidazole	Product containing metronidazole (medicinal product)
Metroplasty (& [Jones] or [Strassman] or [Tomkins])	Strassmann metroplasty (procedure)
Metroplasty (& [Jones] or [Strassman] or [Tomkins])	Tompkins metroplasty
Metroplasty (& [Jones] or [Strassman] or [Tomkins])	Repair of uterus (procedure)
Metroplasty (& [Jones] or [Strassman] or [Tomkins])	Jones modified Strassmann metroplasty (procedure)
Metrorrhagia	Irregular intermenstrual bleeding
Mexiletine hydrochloride 25mg/mL injection solution 10mL ampule	Mexiletine hydrochloride 25 mg/mL solution for injection
Mexiletine hydrochloride 360mg m/r capsule	Product containing precisely mexiletine hydrochloride 360 milligram/1 each prolonged-release oral capsule (clinical drug)
Mg/m2	mg/m2
Miconazole 1% preservative-free eye drops	Miconazole nitrate 10 mg/mL eye drops
Miconazole nitrate 1.2g pessary	Miconazole nitrate 1.2 g vaginal capsule
Miconazole nitrate 2% dusting powder	Miconazole nitrate 20 mg/g cutaneous powder
Micrencephaly	Occipitofrontal circumference of between two and equal to or greater than five standard deviations below the mean for age, sex, and gestation.
Micrencephaly	A rare neurological disorder characterized by a reduced head circumference at birth with no gross anomalies of brain structure. It can be an isolated finding or it can be associated with seizures, developmental delay, intellectual disability, balance disturbances, hearing loss or vision problems.
Microbacterium species	Microbacterium
Microbial medical gas filter, non-sterile, reusable	Medical gas line filter
Microbial medical gas filter, sterile, reusable	Medical gas line filter
Microbiologic agent	Organism (organism)
Microbiology (& [culture - general] or [sensitivity] or [virulence])	Antimicrobial susceptibility test
Microbiology (& [culture - general] or [sensitivity] or [virulence])	Virulence, microbiological test
Microbiology (& [culture - general] or [sensitivity] or [virulence])	Microbiology procedure
Microbiology (& [culture - general] or [sensitivity] or [virulence])	Culture - general
Microbiology test (& [culture - general] or [sample] or [exam - other] or [sensitivity] or [virulence])	Culture - general
Microbiology test (& [culture - general] or [sample] or [exam - other] or [sensitivity] or [virulence])	Culture - general
Microbiology test (& [culture - general] or [sample] or [exam - other] or [sensitivity] or [virulence])	Microbiology procedure
Microbiology test (& [culture - general] or [sample] or [exam - other] or [sensitivity] or [virulence])	Virulence, microbiological test
Microbiology test (& [culture - general] or [sample] or [exam - other] or [sensitivity] or [virulence])	Microbiology procedure
Microbiology test (& [culture - general] or [sample] or [exam - other] or [sensitivity] or [virulence])	Virulence, microbiological test
Microcephalic osteodysplastic dysplasia	Microcephalic osteodysplastic dysplasia, Saul-Wilson type is a skeletal dysplasia characterised by a distinct facial phenotype, short stature, brachydactyly, clubfoot deformities, cataracts, and microcephaly. It has been described in four patients. Facial features include frontal bossing with a depression over the metopic suture, a narrow nasal root with a beaked nose, and midfacial hypoplasia with prominent eyes. Characteristic radiographic findings are observed (irregularities of the vertebral bodies, hypoplasia of the odontoid process, short phalanges, coning several epiphyses etc.).
Microcephalus	A rare neurological disorder characterized by a reduced head circumference at birth with no gross anomalies of brain structure. It can be an isolated finding or it can be associated with seizures, developmental delay, intellectual disability, balance disturbances, hearing loss or vision problems.

Start Previous Page 282 of 498 Next End

Reference Sets

Reference set descriptor

Description inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001150016	POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001151017	POSSIBLY EQUIVALENT TO association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)